An incredible milestone! A letter from Dr. André Veillette

Dear Colleagues,

Five years ago, the Marathon of Hope Cancer Centres Network set out to create Canada’s largest and most complete cancer resource: the MOHCCN Gold Cohort.

Today, we’re proud to announce that we’ve reached our initial goal of sequencing 15,000 cancer genomes.

We are profoundly grateful to every patient, researcher, clinician, donor and administrator who shared their data, knowledge and resources to make this a reality. This incredible achievement would not have been possible without your collaboration and dedication.

Thanks to your efforts, the Gold Cohort will empower researchers for generations to come to ask bold new questions and make data-driven discoveries that will improve the lives of cancer patients. This is a significant milestone in our joint vision to accelerate precision oncology for the benefit of all cancer patients in this country. And we’re just getting started.

The full story on this exciting milestone is below, as are other updates from across the Network. I highly recommend you take the time to read on.

In 1980, Terry Fox started a marathon against cancer. Thank you for everything you do to help us FINISH IT.

Sincerely,

Dr. André Veillette
Executive Director, 
Marathon of Hope Cancer Centres Network

Other news

Network news

Patient voices

Network Voices

  • The importance of biobanks in cancer research. Watch Patient Working Group members, Jennifer Coish and Darrin Park, chat with Dan Loos, the coordinator of BioBank NL about all things biobanking—from why it matters to patients, researchers, and clinicians to how it helps accelerate precision oncology.
  • Putting patient values at the centre of precision oncology. In a new edition of our Network Voices Conversation series, Patient Working Group members, James Pereira and Sheilah Brukewich, chat with Dr. Samantha Pollard about the importance of patient values to shape precision oncology research and care.
  • Meet the Team Canada of Cancer Research: Dr. Sevtap Savas. In our latest Q&A, we spoke to NL-based researcher, Dr. Sevtap Savas, to learn more about her journey to cancer research and how she’s helping to FINISH the marathon against cancer that Terry started in 1980—both in the lab and in her community.

Events

Today, we’re proud to announce that we’ve reached our initial goal of sequencing 15,000 cancer genomes.